List of bibliographic references indexed by might
Number of relevant bibliographic references: 14.
Ident. | Authors (with country if any) | Title |
---|
000062 (2020) |
Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. |
000063 (2020) |
Sheldon H. Preskorn [États-Unis] | The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy. |
000134 (2020) |
Saghir Akhtar [Qatar] ; Ibrahim F. Benter ; Mohammed I. Danjuma [Qatar] ; Suhail A R. Doi [Qatar] ; Syed S. Hasan [Royaume-Uni] ; Abdella M. Habib [Qatar] | Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety. |
000177 (2020) |
Antonio Ceriello [Italie] ; Eberhard Standl [Allemagne] ; Doina Catrinoiu [Roumanie] ; Baruch Itzhak [Israël] ; Nebojsa M. Lalic [Serbie] ; Dario Rahelic [Croatie] ; Oliver Schnell [Allemagne] ; Jan Škrha [République tchèque] ; Paul Valensi | Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era. |
000180 (2020) |
Paul Macdaragh Ryan [Irlande (pays)] ; Noel M. Caplice [Irlande (pays)] | Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019? |
000182 (2020) |
Hisashi Kai [Japon] ; Mamiko Kai [Japon] | Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. |
000224 (2020) |
Anca Pantea Stoian [Roumanie] ; Yajnavalka Banerjee [Émirats arabes unis] ; Ali A. Rizvi [États-Unis] ; Manfredi Rizzo [États-Unis, Italie] | Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. |
000235 (2020) |
Francesco P. Cappuccio [Royaume-Uni] ; Alfonso Siani [Italie] | Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint. |
000284 (2020) |
Dina Radenkovic [Royaume-Uni] ; Shreya Chawla [Royaume-Uni] ; Matteo Pirro [Italie] ; Amirhossein Sahebkar [Iran] ; Maciej Banach [Pologne] | Cholesterol in Relation to COVID-19: Should We Care about It? |
000293 (2020) |
Ben Rowland [Royaume-Uni] ; Vijay Kunadian [Royaume-Uni] | Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic. |
000318 (2020) |
Azita Hajhossein Talasaz [Iran] ; Hessam Kakavand [Iran] ; Benjamin Van Tassell [États-Unis] ; Maryam Aghakouchakzadeh [Iran] ; Parham Sadeghipour [Iran] ; Steven Dunn [États-Unis] ; Babak Geraiely [Iran] | Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. |
000332 (2020) |
F. Moccia [Italie] ; A. Gerbino [Italie] ; V. Lionetti [Italie] ; M. Miragoli [Italie] ; L M Munaron [Italie] ; P. Pagliaro [Italie] ; T. Pasqua [Italie] ; C. Penna [Italie] ; C. Rocca [Italie] ; M. Samaja [Italie] ; T. Angelone [Italie] | COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. |
000345 (2020) |
Matteo Apicella [Italie] ; Maria Cristina Campopiano [Italie] ; Michele Mantuano [Italie] ; Laura Mazoni [Italie] ; Alberto Coppelli [Italie] ; Stefano Del Prato [Italie] | COVID-19 in people with diabetes: understanding the reasons for worse outcomes. |
000354 (2020) |
Tomasz J. Guzik [Royaume-Uni, Pologne] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni, Italie] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni, Pologne] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] | COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "might"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "might" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= might
}}
| This area was generated with Dilib version V0.6.35. Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021 | |